azomycin has been researched along with Kidney Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, R; Bertini, R; Bettinardi, V; Capitanio, U; Cascinu, S; Doglioni, C; Gianolli, L; Incerti, E; Larcher, A; Lucianò, R; Mapelli, P; Monterisi, C; Montorsi, F; Necchi, A; Pepe, G; Picchio, M; Salonia, A; Trevisani, F | 1 |
| Bolton, DM; Davis, ID; Lawrentschuk, N; Scott, AM | 1 |
| Beasley, NJ; Harris, AL; Maxwell, PH; Pastorek, J; Pugh, CW; Ratcliffe, PJ; Sibtain, A; Talks, KL; Turley, H; Turner, KJ; Watson, PH; Wilson, GD; Wykoff, CC | 1 |
| Bryan, GT; Cohen, SM; Crovetti, AJ; Ertürk, E; Von Esch, AM | 1 |
1 review(s) available for azomycin and Kidney Neoplasms
| Article | Year |
|---|---|
Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.
Topics: Acetates; Carcinoma, Renal Cell; Choline; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Staging; Nitroimidazoles; Positron-Emission Tomography; Radioimmunodetection; Radioimmunotherapy; Radiopharmaceuticals | 2006 |
3 other study(ies) available for azomycin and Kidney Neoplasms
| Article | Year |
|---|---|
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial.
Topics: Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Lymph Nodes; Lymphatic Metastasis; Nitroimidazoles; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2021 |
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Topics: Blotting, Western; Carbonic Anhydrases; Carcinoma; Carcinoma, Renal Cell; DNA-Binding Proteins; Endothelial Growth Factors; Genes, Reporter; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Immunohistochemistry; In Situ Hybridization; Kidney Neoplasms; Lymphokines; Models, Genetic; Necrosis; Nitroimidazoles; Nuclear Proteins; Oxygen; Plasmids; Promoter Regions, Genetic; Radiation-Sensitizing Agents; RNA; RNA, Messenger; Skin Neoplasms; Transcription Factors; Tumor Cells, Cultured; Up-Regulation; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Carcinogenicity of 5-nitrofurans, 5-nitroimidazoles, 4-nitrobenzenes, and related compounds.
Topics: Adenocarcinoma; Animals; Benzene Derivatives; Carcinogens; Chemical Phenomena; Chemistry; Diet; Female; Kidney Neoplasms; Leukemia, Experimental; Leukemia, Lymphoid; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Nitrobenzenes; Nitrofurans; Nitroimidazoles; Rats | 1973 |